March 3, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 2346 companies with "abnormal" market making, 3974 companies with positive Friction Factors and 1545 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. NEWMONT MINING CORP (NYSE:NEM), ALKERMES INC (NASDAQ:ALKS), POPULAR INC (NASDAQ:BPOP), YAMANA GOLD INC (NYSE:AUY), AMYLIN PHARMACEUTICALS INC (NASDAQ:AMLN), NYSE EURONEXT (NYSE:NYX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     NEM        $-1.380      -2.52%       6,359,923       48.15%       5,379,748       40.73%       980,175         Abnormal
     ALKS       $-1.740      -12.37%      2,494,637       59.53%       1,555,897       37.13%       938,740         Abnormal
     BPOP       $-0.030      -0.95%       6,120,457       54.16%       5,177,348       45.82%       943,109         Abnormal
     AUY        $-0.080      -0.62%       5,301,508       49.32%       4,148,257       38.59%       1,153,251       Abnormal
     AMLN       $-3.790      -25.25%      12,114,091      53.14%       10,428,500      45.75%       1,685,591       Abnormal
     NYX        $-0.110      -0.30%       3,074,244       70.74%       956,391         22.01%       2,117,853       Abnormal

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more buying than selling on Thursday and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows NEM with 980,175 greater shares of buying than selling (NetVol) and the stock price was down $-1.38000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

NEWMONT MINING CORP (NYSE:NEM) - Newmont Mining Corporation, together with its subsidiaries, engages in the acquisition, exploration, and production of gold and copper properties. Its assets or operations are located in the United States, Australia, Peru, Indonesia, Ghana, Canada, New Zealand, and Mexico. As of December 31, 2009, Newmont had proven and probable gold reserves of approximately 91.8 million equity ounces and an aggregate land position of approximately 33,400 square miles. The company was founded in 1916 and is headquartered in Greenwood Village, Colorado.

ALKERMES INC (NASDAQ:ALKS) - Alkermes, Inc., an integrated biotechnology company, offers extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction, and diabetes. It primarily develops, manufactures, and commercializes VIVITROL, an extended-release Medisorb formulation of naltrexone for the treatment of alcohol dependence, as well as for the treatment of opioid dependence. The company also manufactures RISPERDAL CONSTA, a formulation of risperidone for the treatment of schizophrenia and bipolar disorder. In addition, it is developing Exenatide once weekly for the treatment of type 2 diabetes; ALKS 33, an opioid modulator, which completed phase I randomized, double-blind, and placebo-controlled study for the treatment of addiction, pain, and other nervous system disorders; ALKS 29, an oral combination therapy for the treatment of alcohol dependence; ALKS 27, an inhaled trospium product that is in a phase IIa study for the treatment of chronic obstructive pulmonary disease; and ALKS 36, a co-formulation of an opioid analgesic and RDC-1036 for the treatment of pain. Alkermes, Inc. has collaborative arrangements with Janssen Pharmaceutica, Inc.; Cilag GmbH International; Amylin Pharmaceuticals, Inc.; and Rensselaer Polytechnic Institute. The company was founded in 1987 and is headquartered in Cambridge, Massachusetts.

POPULAR INC (NASDAQ:BPOP) - Popular, Inc., through its subsidiaries, provides a range of retail and commercial banking products and services in Puerto Rico, the United States, Venezuela, the Dominican Republic, El Salvador, and Costa Rica. It also provides vehicle financing, leasing, and daily rental services; mortgage loans; and insurance agency and brokerage, and reinsurance services, as well as offers financial advisory, investment, and security brokerage services for institutional and retail customers. As of December 31, 2008, the company operated 173 branches and approximately 580 automated teller machines in Puerto Rico, 7 branches in the U.S. Virgin Islands, 1 branch in the British Virgin Islands, and 1 branch in New York. In addition, it provides financial transaction processing and information technology solutions and services in the United States, the Caribbean, and Latin America. Further, the company develops financial processing software applications; sells hardware products, such as ATM, POS, and communication products; and provides ATM switching and driving services. Popular was founded in 1917 and is headquartered in Hato Rey, Puerto Rico.

YAMANA GOLD INC (NYSE:AUY) - Yamana Gold Inc. engages in the acquisition, exploration, development, and operation of gold properties. The company also focuses on copper and silver projects. It holds gold production, gold development stage, and exploration stage properties, as well as land positions in Brazil, Chile, Argentina, Mexico, and Colombia. The company has seven producing mines and seven development stage projects. Its principal producing mines include the Chapada, Jacobina, and Fazenda Brasileiro mines located in Brazil; the El Penon and Minera Florida mines in Chile; and the Gualcamayo mine in Argentina. The company was founded in 2003 and is headquartered in Toronto, Canada.

AMYLIN PHARMACEUTICALS INC (NASDAQ:AMLN) - Amylin Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. The companys products include BYETTA (exenatide) injection for the treatment of type 2 diabetes; and SYMLIN (pramlintide acetate) injection for the treatment of type 1 and type 2 diabetes. It also has research and development (R&D) programs in the therapeutic areas of diabetes and obesity. The companys R&D programs for diabetes include exenatide once weekly, exenatide once weekly pen, exenatide suspension formulation, exenatide nasal, and the exenatide transdermal patch. Its R&D programs for obesity comprise pramlintide/metreleptin combination therapy and PYY 3-36. The company markets its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers, and other third-party payers primarily in the United States. It has collaboration agreements Eli Lilly and Company; Alkermes, Inc.; Takeda Pharmaceutical Company Limited; Biocon, Ltd.; and BioSeek, Inc. The company was founded in 1987 and is based in San Diego, California.

NYSE EURONEXT (NYSE:NYX) - NYSE Euronext, through its subsidiaries, provides securities listing, trading, market data products, and software and technology services worldwide. The company offers products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, market data, and commercial technology solutions to issuers, investors, financial institutions, and market participants. It operates NYSE, the New York Stock Exchange, which lists various debt and equity structured products, such as capital securities, mandatory convertibles, and repackaged securities; and NYSE Arca, an electronic exchange for equities, exchange traded funds, exchange traded notes, exchange-traded vehicles, certificates, and options. The company also operates Euronext that lists various securities, including domestic and international equity securities, convertible bonds, warrants, trackers, and debt securities, including corporate and government bonds. In addition, it operates NYSE Liffe that trades futures and options contracts; NYSE Arca Europe, which offers electronic, low latency trading platform for blue chip stocks; NYSE Alternext operates its European markets for emerging growth companies; NYSE Amex, which lists various classes of companies that are qualified for listing on NYSE; NYSE Liffe US that trades full and mini-sized gold and silver futures and options on futures contracts; and SmartPool, a European dark pool dedicated to the execution of institutional order flow. Further, the company operates distributed connectivity network that supports trading on its markets, as well as provides trading and information technology solutions. Additionally, it operates secure financial transaction infrastructure network, a physical network infrastructure that connects its markets and other market centers. The company is headquartered in New York, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Like: 👍